Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpwin Grp Regulatory News (EPWN)

  • This share is currently suspended. It was suspended at a price of 119.50
  • There is currently no data for EPWN

Form 8.3 - Epwin Group plc

22 Sep 2025 15:00

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Epwin Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

19 September 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

0.05p ordinary

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

2,235,091

 

1.64%

 

 

(2) Cash-settled derivatives:

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

2,235,091

 

1.64%

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

 

Purchase/sale

 

Number of securities

 

Price per unit

0.05p ordinary

Purchase

15,000

118.5p

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

 

No

Date of disclosure:

 

22 September 2025

Contact name:

 

Abel Romero

Telephone number:

 

+44 20 3770 8625

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250922919465/en/

Copyright Business Wire 2025

Date   Source Headline
13th Jul 20212:19 pmRNSBlock Listing Application
9th Jul 202111:05 amRNSBlock Listing Six Monthly Return
1st Jul 202112:02 pmRNSTotal Voting Rights
7th Jun 20211:39 pmRNSTotal Voting Rights
28th May 20217:00 amRNSDirector/PDMR Shareholding
25th May 20212:03 pmRNSResults of Annual General Meeting
25th May 20217:00 amRNSAGM trading update
30th Apr 20211:00 pmRNSAnnual Report and Accounts 2020 and 2021 AGM
15th Apr 20217:00 amRNSFinal Results
6th Apr 20212:35 pmRNSTotal Voting Rights
1st Mar 20215:29 pmRNSTotal Voting Rights
26th Feb 20214:41 pmRNSSecond Price Monitoring Extn
26th Feb 20214:36 pmRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSYear-end trading update and acquisition
19th Jan 20217:00 amRNSExercise of Options and Transaction in Own Shares
5th Jan 20217:00 amRNSBlock listing application
16th Dec 20207:05 amRNSIssue of Shares
16th Dec 20207:00 amRNSTrading Update and Notice of Results
22nd Oct 20207:00 amRNSGrant of Options under SAYE Scheme
5th Oct 20203:54 pmRNSHolding(s) in Company
10th Sep 20207:00 amRNSHalf-year results
8th Sep 20204:48 pmRNSIssue of Shares
6th Aug 20207:00 amRNSTrading Update and Notice of Results
23rd Jul 20207:00 amRNSHolding(s) in Company
22nd Jul 202012:31 pmRNSHolding(s) in Company
16th Jun 20201:48 pmRNSResults of AGM
16th Jun 20207:00 amRNSAGM trading update
28th May 20207:00 amRNSOperational update
13th May 20202:31 pmRNSAnnual Report and Accounts 2019 and 2020 AGM
29th Apr 20203:42 pmRNSHolding(s) in Company
23rd Apr 20207:00 amRNSFinal results for the year ended 31 December 2019
25th Mar 202011:27 amRNSCOVID-19 update and notice of results
25th Feb 20203:45 pmRNSIssue of Shares
30th Jan 20202:34 pmRNSHolding(s) in Company
23rd Jan 20207:00 amRNSYear-end trading update and notice of results
27th Dec 20192:59 pmRNSHolding(s) in Company
22nd Nov 201912:08 pmRNSHolding(s) in Company
21st Nov 20194:06 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSAppointment of Shore Capital
11th Sep 20197:00 amRNSHalf year results
8th Aug 20197:00 amRNSHalf Year Trading Update and Notice of Results
15th Jul 201912:07 pmRNSSecond Price Monitoring Extn
15th Jul 201912:02 pmRNSPrice Monitoring Extension
21st May 20193:26 pmRNSResults of Annual General Meeting
21st May 20197:00 amRNSAGM Trading Update
8th May 201912:47 pmRNSDirector's Dealing
29th Apr 20199:43 amRNSHolding(s) in Company
18th Apr 20193:26 pmRNSAnnual Report and Accounts 2018 and Notice of AGM
10th Apr 20197:00 amRNSFinal results for the year ended 31 December 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.